ARTICLE | Company News
T Cell Sciences, Virus Research deal
August 24, 1998 7:00 AM UTC
The companies completed their merger (see BioCentury, May 18). The merged entity, Avant Immunotherapeutics Inc. (Needham, Mass.) will begin trading on NASDAQ on Aug. 24 under the symbol AVAN. ...